<div id="readability-page-1"><div><p><span>Britain has promised the United States that spending on National Health Service (NHS) medicines will rise by 1.5 billion pounds ($2 billion) over the next three years, the Financial Times said on Thursday.</span></p><p><span>The pledge is part of a deal to win exemption from drug import levies threatened by U.S. President Donald Trump, that aims to boost such spending to 0.35% of GDP from 0.3% by the end of 2028, the paper said, citing people familiar with the deal.</span></p><p><span>Reuters could not immediately verify the report.</span></p><p><span>($1=0.7482 pounds)</span></p></div></div>

<p>The UK has pledged to increase NHS spending by $2 billion over three years to avoid US drug import tariffs. This deal aims to raise NHS medicine spending to 0.35% of GDP by 2028, as reported by the Financial Times. Reuters has not verified this report.</p>

UK pledges extra $2 billion NHS spend to avert Trump tariffs, FT says